Free Pulmonology CME | CMEList.com

 


Alpha-1 antitrypsin deficiency (AATD): improving treatment and reducing barriers to care
Free Pulmonology CME Posted by...Bernard Sklar, MD.
Free Pulmonology and Genetics CME Credit Hours...1.0.
CME Credits Awarded by....ScientiaCME.
Cost..........Free.
Instruction Type....Slide-Video Lectures.
Target Audiences....Pulmonologists and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in pulmonology and internal medicine; and any other healthcare professionals with an interest in or who clinically encounter patients with AATD.
Educational material last updated...June 26, 2017.
Expiration of CME credit...June 26, 2019.
Financial Support...Grifols.
Topics covered in Alpha-1 antitrypsin deficiency (AATD): improving treatment and reducing barriers to care include:
Epidemiology, clinical features, presentation, pathophysiology, and disease progression, patient population identification among healthcare professionals of different specialties, diagnostic tests, genetic testing and patient cases.
After completing Alpha-1 antitrypsin deficiency (AATD): improving treatment and reducing barriers to care , you will be able to:
• Describe the pathophysiology of AATD and how it impacts treatment of the disorder
• Assess the clinical significance of AATD laboratory results and apply them to patient cases
• Describe the clinical presentation of patients with A1ATD and, given a patient case, formulate a treatment plan
• Recall barriers to care for AATD and its clinical management in current practice

Pilot for Pulmonary COPD Expert Interviews
Free Pulmonology CME Posted by...Bernard Sklar, MD.
Free Pulmonology CME Credit hours...0.75. (3 sections, 0.25 credits each)
CME Credits Awarded by....The France Foundation
Cost...........Free.
Instruction Type...Video commentary
Target Audiences...Pulmonologists, critical care clinicians and other healthcare professionals involved in the management of patients with COPD.
Educational material updated....May 31, 2017.
Expiration of CME credit...May 31, 2018.
Financial Support...Boehringer Ingelheim Pharmaceuticals.
Pilot for Pilot for Pulmonary COPD Expert Interviews reviews topics including:
• What is the 2017 GOLD standard for managing patients with COPD?
• Stepping up or stepping down - which direction for COPD patients?
• Is the delivery system a good match for your patients with COPD?
After completing the Pilot for Pilot for Pulmonary COPD Expert Interviews, you should be better able to:
• Examine the data and expert recommendations concerning the use of ICS in patients with COPD
• Evaluate data on the use of single and combination bronchodilators in patents with COPD
• Discuss clinical scenarios where ICS should or should not be considered